Lista de obras - Stan Heptinstall - Dominio Público Uruguay

A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies

scientific article published on 01 October 1999

ADP-induced platelet aggregation and actin polymerization. Involvement of GpIIb/IIIa and the effect of Mg2+

scientific article published on 01 January 1995

Activation of leukocytes in whole blood samples by N-formyl-methionyl-leucyl-phenylalanine (FMLP) enhances platelet aggregability but not platelet P-selectin exposure and adhesion to leukocytes

artículo científico publicado en 1998

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

artículo científico publicado en 2017

Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial.

artículo científico publicado en 2016

Circulating Microparticles in Patients with Symptomatic Carotid Disease Are Related to Embolic Plaque Activity and Recent Cerebral Ischaemia

Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disorders.

artículo científico publicado en 2018

Cocoa flavanols and platelet and leukocyte function: recent in vitro and ex vivo studies in healthy adults

artículo científico publicado en 2006

DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease

artículo científico publicado en 2008

Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke

artículo científico publicado en 2006

Effect of high glucose concentrations on spontaneous aggregation of human blood platelets

artículo científico publicado el 1 de enero de 1988

Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganisation, on platelet function

scientific article published on 01 December 2000

Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood

artículo científico publicado en 1995

Enhanced platelet aggregation and activation under conditions of hypothermia

artículo científico publicado en 2007

Evidence that adenosine diphosphate can activate adenylate cyclase via conversion to adenosine in platelet-rich plasma containing magnesium

artículo científico publicado el 1 de agosto de 1998

Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood

artículo científico publicado en 1995

Formation of platelet-leukocyte conjugates in whole blood

artículo científico publicado en 1997

How can we inhibit 5-HT-induced platelet aggregation and why should we bother?

artículo científico publicado en 1988

How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy?

artículo científico publicado en 2018

Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1.

artículo científico publicado en 2004

Inhibition of platelet aggregation by transdermal glyceryl trinitrate

artículo científico publicado en 1994

Inhibition of platelet behaviour by feverfew: a mechanism of action involving sulphydryl groups

artículo científico publicado en 1988

Interactions of platelets with Synthocytes, a novel platelet substitute

artículo científico publicado en 2002

Leukocytosis, vascular disease, and adenine nucleotide metabolism

artículo científico publicado en 2006

Measurement of platelet activation and adhesion to leukocytes during haemodialysis

artículo científico publicado en 1998

Multiple electrode aggregometry and P2Y(12) antagonists

artículo científico publicado en 2008

P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist

artículo científico publicado en 2003

Platelet aggregation and intracellular calcium mobilisation responses are enhanced by cyclosporin A but not by pimecrolimus (SDZ ASM 981).

artículo científico publicado en 2002

Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter

artículo científico publicado en 1982

Platelet aggregation measured by single-platelet counting and using PFA-100 devices

artículo científico publicado en 2018

Platelet function reduces significantly during the morning

artículo científico publicado en 2008

Platelet-monocyte interaction and GPIIb/IIIa blockade

scientific article published on 01 October 2004

Quantitation of platelet aggregation and microaggregate formation in whole blood by flow cytometry

artículo científico publicado en 2004

Remote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic Attack

artículo científico publicado en 2017

Remote platelet function testing using P-selectin expression in patients with recent cerebral ischaemia on clopidogrel

scientific article published on 24 September 2020

Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood

scientific article published on 01 January 1998

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARD

artículo científico publicado en 2015

The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro

artículo científico publicado en 2002

The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions

artículo científico publicado en 2003

Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P

artículo científico publicado en 2002

Triple antiplatelet therapy for secondary prevention of recurrent ischemic stroke

artículo científico publicado en 2004

Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT

article

UDP-sugars activate P2Y14 receptors to mediate vasoconstriction of the porcine coronary artery

artículo científico publicado en 2017

Lista de obras de Stan Heptinstall

A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies

ADP-induced platelet aggregation and actin polymerization. Involvement of GpIIb/IIIa and the effect of Mg2+

Activation of leukocytes in whole blood samples by N-formyl-methionyl-leucyl-phenylalanine (FMLP) enhances platelet aggregability but not platelet P-selectin exposure and adhesion to leukocytes

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial.

Circulating Microparticles in Patients with Symptomatic Carotid Disease Are Related to Embolic Plaque Activity and Recent Cerebral Ischaemia

Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disorders.

Cocoa flavanols and platelet and leukocyte function: recent in vitro and ex vivo studies in healthy adults

DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease

Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke

Effect of high glucose concentrations on spontaneous aggregation of human blood platelets

Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganisation, on platelet function

Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood

Enhanced platelet aggregation and activation under conditions of hypothermia

Evidence that adenosine diphosphate can activate adenylate cyclase via conversion to adenosine in platelet-rich plasma containing magnesium

Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood

Formation of platelet-leukocyte conjugates in whole blood

How can we inhibit 5-HT-induced platelet aggregation and why should we bother?

How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy?

Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1.

Inhibition of platelet aggregation by transdermal glyceryl trinitrate

Inhibition of platelet behaviour by feverfew: a mechanism of action involving sulphydryl groups

Interactions of platelets with Synthocytes, a novel platelet substitute

Leukocytosis, vascular disease, and adenine nucleotide metabolism

Measurement of platelet activation and adhesion to leukocytes during haemodialysis

Multiple electrode aggregometry and P2Y(12) antagonists

P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist

Platelet aggregation and intracellular calcium mobilisation responses are enhanced by cyclosporin A but not by pimecrolimus (SDZ ASM 981).

Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter

Platelet aggregation measured by single-platelet counting and using PFA-100 devices

Platelet function reduces significantly during the morning

Platelet-monocyte interaction and GPIIb/IIIa blockade

Quantitation of platelet aggregation and microaggregate formation in whole blood by flow cytometry

Remote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic Attack

Remote platelet function testing using P-selectin expression in patients with recent cerebral ischaemia on clopidogrel

Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARD

The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro

The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions

Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P

Triple antiplatelet therapy for secondary prevention of recurrent ischemic stroke

Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT

UDP-sugars activate P2Y14 receptors to mediate vasoconstriction of the porcine coronary artery